Corrigendum: MRI-guided focal or integrated boost high dose rate brachytherapy for recurrent prostate cancer.
Ménard C, Navarro-Domenech I, Liu ZA, Joseph L, Barkati M, Berlin A, Delouya G, Taussky D, Beauchemin MC, Nicolas B, Kadoury S, Rink A, Raman S, Sundaramurthy A, Weersink R, Beliveau-Nadeau D, Helou J, Chung P.
Ménard C, et al. Among authors: beliveau nadeau d.
Front Oncol. 2022 Nov 17;12:1084708. doi: 10.3389/fonc.2022.1084708. eCollection 2022.
Front Oncol. 2022.
PMID: 36465337
Free PMC article.